CSL Behring
HAEGARDA
Manufacturer:
CSL Behring
Name:
HAEGARDA
Category:
J Code
HCPCS:
J0599
NDC(s):
63833-0828-02, 63833-0829-02,
Primary Type:
C1 Esterase Inhibitor
Route of Administration:
Subcutaneous
About:
HAEGARDA is a C1 Esterase Inhibitor drug manufactured by CSL Behring and administered via the Subcutaneous route of administration. The J Code: J0599 is aligned to the drug HAEGARDA.